Searched for
NUTRACEUTICAL PRICING ISSUES
Vahh Chemicals shares list at 17% premium over IPO price on BSE SME platformVahh Chemicals Listing: Vahh Chemicals debuted on the BSE SME platform with a nearly 17% premium, listing at Rs 70 against its IPO price of...- Vahh Chemicals IPO: Check GMP, price band, subscription and other detailsVahh Chemicals' Initial Public Offering opens for subscription on Thursday. Grey market indicators suggest robust investor interest. The co...
- For both the compulsive trader and careful investor: 25 stocks to watch if risk appetite returns; some with upside potential, some notIf the price of crude oil softens, Indian equities may again see a risk-on phase. Tariff concerns are no longer the central issue; the larg...
- Quality and branding: The twin pillars of India’s global horticulture pushA coordinated push involving policy support, private investment, and technology adoption can help India shift from volume-driven to value-l...
- Drug regulator oversight sought for nutraceuticals; NGO flags quality, pricing concernsA Gujarat NGO is pushing the government to regulate nutraceuticals like medicines. They cite concerns about product quality and unregulated...
- Aptus Pharma IPO opens for subscription today. GMP, price band among key things to knowAptus Pharma is set to launch its IPO on Tuesday. The company aims to raise Rs 13.02 crore through a fresh issue. The IPO price is fixed be...
- Medistep Healthcare shares list at 23% premium over IPO price on NSE SME platformMedistep Healthcare's shares began trading on the NSE SME platform. The shares opened at Rs 53, a 23% increase from the initial price of Rs...
- Medistep Healthcare IPO opens today. Check GMP, issue size, price band and other detailsMedistep Healthcare, an Ahmedabad-based pharmaceutical and wellness company, is launching its Rs 16.10 crore IPO on August 8 via the NSE SM...
- Influx Healthtech shares list at 38% premium over IPO price on NSE SMEInflux Healthtech debuted strongly on the NSE SME platform, listing at Rs 132.5 per share, a 38% premium over its IPO price of Rs 96. The R...
- Influx Healthtech IPO subscribed over 41 times on Day 3; GMP signals strong listingInflux Healthtech's IPO witnessed an overwhelming response, being oversubscribed 41.07 times, driven by strong retail and NII participation...
- Influx Healthtech IPO subscribed 1.7 times on Day 1; GMP points to strong listing popInflux Healthtech IPO: In the unlisted market, Influx Healthtech’s grey market premium (GMP) was Rs 42 at 11:54 AM on Wednesday, suggesting...
- Influx Healthtech IPO opens today: Check key details before subscribingInflux Healthtech, a Mumbai-based CDMO, launches its IPO today, aiming to raise ₹55.63 crore through a fresh issue and offer-for-sale. The ...
- Patanjali Foods' profit surges despite revenue dip, edible oil boosts bottomlineIn a quarter when the promoters of Patanjali Foods - yoga guru Baba Ramdev and aide Acharya Balkrishna - had to issue an apex court-ordered...
- Pharma companies against plan to bring nutraceuticals under drug regulatorControversy arises as government considers shifting nutraceuticals to drug regulatory authority from FSSAI oversight. Industry experts expr...
- Nutraceuticals may get cheaper as panel looks to regulate pricesThe Indian government is contemplating bringing nutraceuticals under price control to enhance affordability for consumers. Currently regula...
- Govt panel to review if nutraceuticals should be brought under CDSCONutraceuticals are products derived from food sources that are believed to provide extra health benefits besides the basic nutritional valu...
- Historic debut! Sigachi Industries lists on stock exchanges at a premium of 252%The initial stake sale of Sigachi Industries was open for subscription between November 1-3. It raised Rs 125.43 crore via the primary rout...
- SME IPO Valencia Nutrition kicks off; issue receives bids for 84,000 sharesBy 11.45 pm, the issue had received bids for 84,000 shares on BSE.
- Open to changes in new standards for food supplements: FSSAIFSSAI CEO Pawan Kumar Agarwal expressed concern over the increasing number of spurious food supplement products in the market.
- Advanced Enzyme IPO hits market today: Should you grab it or avoidThe firm will issue shares of Rs 50 crore, making the offer size Rs 412 crore. Bids can be made for a minimum of 16 shares and in multiples...
Load More
